CAPFX
Price
$8.97
Change
+$0.02 (+0.22%)
Updated
Jul 3 closing price
Net Assets
665.51M
HBLYX
Price
$15.02
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Net Assets
11.95B
Interact to see
Advertisement

CAPFX vs HBLYX

Header iconCAPFX vs HBLYX Comparison
Open Charts CAPFX vs HBLYXBanner chart's image
Federated Hermes Capital Income F
Price$8.97
Change+$0.02 (+0.22%)
VolumeN/A
Net Assets665.51M
Hartford Balanced Income Y
Price$15.02
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets11.95B
CAPFX vs HBLYX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CAPFX vs. HBLYX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPFX is a Buy and HBLYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLYX has more cash in the bank: 12B vs. CAPFX (666M). HBLYX pays higher dividends than CAPFX: HBLYX (3.51) vs CAPFX (3.28). CAPFX was incepted earlier than HBLYX: CAPFX (29 years) vs HBLYX (19 years). CAPFX (1.10) is less costly to investors than HBLYX (0.67). HBLYX is a more actively managed with annual turnover of: 61.00 vs. CAPFX (31.00). CAPFX has a lower initial minimum investment than HBLYX: CAPFX (1500) vs HBLYX (250000). CAPFX annual gain was more profitable for investors over the last year : 10.04 vs. HBLYX (6.98). CAPFX return over 5 years is better than : 39.32 vs. HBLYX (19.46).
CAPFXHBLYXCAPFX / HBLYX
Total Expense Ratio0.900.67134%
Annual Report Gross Expense Ratio1.100.67164%
Fund Existence29 years19 years-
Gain YTD5.2116.27883%
Front Load1%N/A-
Min. Initial Investment15002500001%
Min. Initial Investment IRA250N/A-
Net Assets666M12B6%
Annual Yield % from dividends3.283.5193%
Returns for 1 year10.046.98144%
Returns for 3 years27.7317.09162%
Returns for 5 years39.3219.46202%
Returns for 10 years57.1044.69128%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NB2.410.07
+2.99%
NioCorp Developments Ltd
ARCC22.410.15
+0.67%
Ares Capital Corp
SOPA1.36N/A
N/A
Society Pass Incorporated
ZJYL0.64N/A
-0.06%
JIN MEDICAL INTERNATIONAL Ltd
ARWR16.79-0.11
-0.65%
Arrowhead Pharmaceuticals